EGFR inhibition in the treatment of non‐small cell lung cancer
DE Gerber - Drug development research, 2008 - Wiley Online Library
Epidermal growth factor receptor (EGFR) inhibitors have introduced the concept of targeted
therapy to the treatment of non‐small cell lung cancer (NSCLC). These agents appear most …
therapy to the treatment of non‐small cell lung cancer (NSCLC). These agents appear most …
[HTML][HTML] EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
DE Gerber - Drug development research, 2008 - ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) inhibitors have introduced the concept of targeted
therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most …
therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most …
EGFR inhibition in the treatment of non‐small cell lung cancer
DE Gerber - Drug Development Research, 2008 - Wiley Online Library
Epidermal growth factor receptor (EGFR) inhibitors have introduced the concept of targeted
therapy to the treatment of non‐small cell lung cancer (NSCLC). These agents appear most …
therapy to the treatment of non‐small cell lung cancer (NSCLC). These agents appear most …
EGFR inhibition in the treatment of non-small cell lung cancer
DE Gerber - Drug Development Research, 2008 - utsouthwestern.elsevierpure.com
Abstract (Table Presented) Epidermal growth factor receptor (EGFR) inhibitors have
introduced the concept of targeted therapy to the treatment of non-small cell lung cancer …
introduced the concept of targeted therapy to the treatment of non-small cell lung cancer …
EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer.
DE Gerber - Drug Development Research, 2008 - europepmc.org
Epidermal growth factor receptor (EGFR) inhibitors have introduced the concept of targeted
therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most …
therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most …
EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
DE Gerber - Drug development research, 2008 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) inhibitors have introduced the concept of targeted
therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most …
therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most …
[引用][C] EGFR inhibition in the treatment of non-small cell lung cancer
DE Gerber - Drug Development Research, 2008 - cir.nii.ac.jp
EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer.
DE Gerber - Drug Development Research, 2008 - europepmc.org
Epidermal growth factor receptor (EGFR) inhibitors have introduced the concept of targeted
therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most …
therapy to the treatment of non-small cell lung cancer (NSCLC). These agents appear most …